GlassScriptPhysician profile
Jaclyn Shaver
NPI 1376825596
$1,892.47
in general payments reported to CMS, 2019-2025
17 companies · $715 in 2025
The $715 reported for 2025 was more than what 92% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $60.62 · 2023: $313 · 2024: $697 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $328.06 | 2023-2025 | Enhertu, Vanflyta |
| Merck Sharp & Dohme LLC | $304.14 | 2023-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $294.91 | 2021-2025 | Enhertu, Lynparza |
| Glaxosmithkline, LLC. | $167.72 | 2024-2025 | |
| Astellas Pharma US INC | $133.35 | 2024-2025 | Veozah |
| Myriad Genetic Laboratories, INC. | $104.20 | 2021-2024 | Myrisk |
| Lilly USA, LLC | $102.88 | 2023-2025 | Verzenio, Retevmo |
| Genmab U.S., INC. | $83.28 | 2022-2025 | Tivdak |
| Seagen INC. | $70.89 | 2023 | Tukysa |
| Eisai INC. | $69.17 | 2024-2025 | |
| Genentech USA, INC. | $48.96 | 2024-2025 | Phesgo |
| Tersera Therapeutics LLC | $43.78 | 2023-2024 | Zoladex |
| Stemline Therapeutics INC. | $41.67 | 2025 | Orserdu |
| Puma Biotechnology, INC. | $32.47 | 2024-2025 | |
| Abbvie INC. | $31.17 | 2024-2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $21.17 | 2025 | Jakafi |
| Gilead Sciences, INC. | $14.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Shaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.